Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci
- 1 November 2003
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 9 (11) , 1120-1124
- https://doi.org/10.1046/j.1469-0691.2003.00765.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococciJournal of Antimicrobial Chemotherapy, 2002
- BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental EndocarditisAntimicrobial Agents and Chemotherapy, 2002
- In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 2001
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- THE RATE OF BACTERICIDAL ACTION OF PENICILLIN IN VITRO AS A FUNCTION OF ITS CONCENTRATION, AND ITS PARADOXICALLY REDUCED ACTIVITY AT HIGH CONCENTRATIONS AGAINST CERTAIN ORGANISMSThe Journal of Experimental Medicine, 1948